SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 81 filers reported holding SERES THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 4.93 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $591,437 | -20.2% | 248,503 | +60.7% | 0.00% | 0.0% |
| Q2 2023 | $740,836 | +36.8% | 154,663 | +61.9% | 0.00% | 0.0% |
| Q1 2023 | $541,706 | +56.7% | 95,539 | +54.8% | 0.00% | 0.0% |
| Q4 2022 | $345,671 | -99.9% | 61,727 | -32.1% | 0.00% | 0.0% |
| Q3 2022 | $583,283,000 | +977.4% | 90,854 | +475.6% | 0.00% | – |
| Q2 2022 | $54,136,000 | -83.7% | 15,783 | -66.2% | 0.00% | – |
| Q1 2022 | $332,867,000 | -83.2% | 46,751 | -80.4% | 0.00% | -100.0% |
| Q4 2021 | $1,985,056,000 | +2176.8% | 238,302 | +1802.3% | 0.00% | – |
| Q3 2021 | $87,188,000 | +39.5% | 12,527 | +377.9% | 0.00% | – |
| Q2 2021 | $62,511,000 | -55.5% | 2,621 | -61.5% | 0.00% | – |
| Q1 2021 | $140,341,000 | -6.8% | 6,816 | +10.9% | 0.00% | – |
| Q4 2020 | $150,602,000 | -57.5% | 6,147 | -50.9% | 0.00% | -100.0% |
| Q3 2020 | $354,441,000 | +3744.3% | 12,520 | +546.4% | 0.00% | – |
| Q2 2020 | $9,220,000 | -77.2% | 1,937 | -82.9% | 0.00% | – |
| Q1 2020 | $40,523,000 | +171.5% | 11,351 | +162.4% | 0.00% | – |
| Q4 2019 | $14,925,000 | -29.5% | 4,326 | -18.1% | 0.00% | – |
| Q3 2019 | $21,169,000 | +179.5% | 5,279 | +124.4% | 0.00% | – |
| Q2 2019 | $7,573,000 | -74.6% | 2,352 | -45.8% | 0.00% | – |
| Q1 2019 | $29,809,000 | +1489.0% | 4,339 | +945.5% | 0.00% | – |
| Q4 2018 | $1,876,000 | -65.9% | 415 | -42.8% | 0.00% | – |
| Q3 2018 | $5,503,000 | -32.5% | 725 | -23.5% | 0.00% | – |
| Q2 2018 | $8,153,000 | -74.6% | 948 | -78.3% | 0.00% | – |
| Q1 2018 | $32,127,000 | -21.9% | 4,377 | +7.9% | 0.00% | – |
| Q4 2017 | $41,128,000 | +18.7% | 4,056 | +87.7% | 0.00% | – |
| Q3 2017 | $34,662,000 | +35.3% | 2,161 | -4.7% | 0.00% | – |
| Q2 2017 | $25,628,000 | +519.6% | 2,268 | +518.0% | 0.00% | – |
| Q1 2017 | $4,136,000 | -28.6% | 367 | -37.3% | 0.00% | – |
| Q4 2016 | $5,792,000 | -70.5% | 585 | -63.3% | 0.00% | – |
| Q3 2016 | $19,603,000 | -4.1% | 1,595 | +126.6% | 0.00% | – |
| Q2 2016 | $20,451,000 | +277.5% | 704 | +245.1% | 0.00% | – |
| Q1 2016 | $5,418,000 | -89.4% | 204 | -86.0% | 0.00% | – |
| Q4 2015 | $51,232,000 | +8.6% | 1,460 | -8.3% | 0.00% | – |
| Q3 2015 | $47,187,000 | – | 1,592 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 14,378,802 | $342,935,000 | 4.38% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 122,700 | $2,926,000 | 1.30% |
| COMMODORE CAPITAL LP | 145,453 | $3,469,000 | 1.21% |
| Asymmetry Capital Management, L.P. | 63,259 | $1,509,000 | 1.04% |
| Opaleye Management Inc. | 250,000 | $5,963,000 | 0.99% |
| Ikarian Capital, LLC | 500,000 | $11,924,000 | 0.96% |
| HighVista Strategies LLC | 44,750 | $1,068,000 | 0.76% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 63,915 | $1,524,000 | 0.68% |
| Altium Capital Management LP | 104,626 | $2,495,000 | 0.58% |
| Integral Health Asset Management, LLC | 75,000 | $1,789,000 | 0.49% |